Cognition in Parkinson's disease

Aim. Studies of accentuated drop in cognitive functioning in Parkinson's disease mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The main goal of this study was to investigate the possible differential drop in different co...

Full description

Permalink: http://skupni.nsk.hr/Record/ffzg.KOHA-OAI-FFZG:305900/Details
Matična publikacija: Croatian medical journal
45 (2004), str. 451-456
Glavni autori: Bašić, Jasna (-), Katić, Silvija (Author), Vranić, Andrea, Zarevski, Predrag, Babić, Tomislav, Mahović-Lakušić, Darija
Vrsta građe: Članak
Jezik: eng
LEADER 02982naa a2200289uu 4500
008 131105s2004 xx eng|d
035 |a (CROSBI)162784 
040 |a HR-ZaFF  |b hrv  |c HR-ZaFF  |e ppiak 
100 1 |a Bašić, Jasna 
245 1 0 |a Cognition in Parkinson's disease /  |c Bašić, Jasna ; Katić, Silvija ; Vranić, Andrea ; Zarevski, Predrag ; Babić, Tomislav ; Mahović-Lakušić, Darija. 
300 |a 451-456  |f str. 
363 |a 45  |i 2004 
520 |a Aim. Studies of accentuated drop in cognitive functioning in Parkinson's disease mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The main goal of this study was to investigate the possible differential drop in different cognitive tasks. Applied tests tapped fluid and crystallized intelligence, memory and metacognition. Method. A sample of 116 participants participated in the study. Half of the participants were diagnosed with Parkinson's disease (average duration of disease was 6.5± ; ; 5.68 years) and control group participants equaled them in age, sex and educational level. All participants were tested using Raven's Colored Progressive Matrices (CPM), Crichton Vocabulary Scale (CVS), memory subtests from Wechsler Adult Intelligence Scale (WAIS DS-F, WAIS DS-B), and Mini-mental Status Examination (MMSE). All participants were questioned concerning their metamemory and metacognition. In case of the clinical group 24 caregivers were asked about metamemory and metacognition of Parkinson’ s patients. Results. Parkinson's disease patients scored significantly lower than control group on CPM (F=18.14, p=0.001) and MMSE (F=4.04, p=0.047). Self-perceived speed of understanding was lower in Parkinson’ s patients (Mclinical=0.76± ; ; 0.43 ; Mcontrol=0.51± ; ; 0.51 ; F=6.57, p=0.012). Patients found their accuracy of metacognition to be more impaired than their caregivers did (Mpatient=0.83± ; ; 0.38 ; Mcaregiver=0.54± ; ; 0.51 ; t=2.29, p=0.035). Conclusion. The results point to a more pronounced cognitive damage of Parkinson's patients in fluid intelligence as opposed to crystallized intelligence. A brief investigation of metamemory and metacognition showed that patients with Parkinson's disease have a relatively accurate metamemory and metacognition. 
536 |a Projekt MZOS  |f 0130425 
546 |a ENG 
690 |a 5.06 
693 |a Parkinson's disease, cognition, intelligence, memory, metacognition  |l hrv  |2 crosbi 
693 |a Parkinson's disease, cognition, intelligence, memory, metacognition  |l eng  |2 crosbi 
700 1 |a Katić, Silvija  |4 aut 
700 1 |a Vranić, Andrea  |4 aut  |9 1013 
700 1 |a Zarevski, Predrag  |4 aut  |9 1006 
700 1 |a Babić, Tomislav  |4 aut 
700 1 |a Mahović-Lakušić, Darija  |4 aut 
773 0 |t Croatian medical journal  |x 0353-9504  |g 45 (2004), str. 451-456 
942 |c CLA  |t 1.01  |u 2  |z Znanstveni - clanak 
962 |w WOS:000223463200015  |s 2-s2.0-4444318707 
999 |c 305900  |d 305898